All Episodes
Citeline Podcasts — 579 episodes
The Economic and Social Value Of Probiotics, With IPA Europe’s Rosanna Pecere
‘빅 드럭’ 시대 본격화…글로벌 제약 매출, 2조 달러 넘을 듯 (Korean-language podcast) June 29, 2026
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 29, 2026
Scrip's Five Must-Know Things - June 29, 2026
Drug Fix: US FDA’s New Guidance On One-Trial Efficacy Standard And IND Reform Pilot
Elevate Clinical Operations into a Board Level Strategic Advantage
China’s New Trial Data Protection Framework: Protection Time And Impact
The Insight Room: Catching the Deadliest Cancer Earlier - Inside the PRECEDE–Azenta Partnership
The Yescarta Launch Examined
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 22, 2026
Scrip's Five Must-Know Things - June 22, 2026
The Generics Bulletin Podcast: Probing The Patent Monopoly With I-MAK’s Tahir Amin
Philips' Shez Partovi on increasing AI adoption, clinicians' attitudes and the hybrid care model
The Socio-Economic Case For Prevention, With Deloitte’s Elizabeth Hampson
Drug Fix: WuXi vs. the Pentagon, New Advertising Citations, And FDA Explores The Limits Of AI
【3分で解説 #世界のファーマ】第29回【トランプ関税で注目】米国、医薬品不足のいま (Japanese-language podcast)
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 15, 2026
Scrip's Five Must-Know Things - Jun. 15, 2026
플랙쉽 파이오니어링, 한국서 장기적 파트너십, 바이오 생태계 성장 모색 (Korean-language podcast)
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 8, 2026
Scrip's Five Must-Know Things - June 1, 2026
Scrip's Five Must-Know Things - June 8, 2026
Drug Fix: SCOTUS Rules On Generic Skinny Labels, US FDA’s NPV Faces Uncertain Future
Ambu CEO Britt Meelby Jensen on EU competitivity and compromise
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 1, 2026
Decoding Cell Stress at Soley Therapeutics
Drug Fix: Potential Nondisclosure Agreements For US FDA Staff, Hiring Threatens User Fee Reductions
Scrip's Five Must-Know Things - May 25, 2026
Optimise Clinical Trial Execution with Smarter Outsourcing and Patient-Focused Design
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 25, 2026
Drug Fix: What’s Next For US FDA After Senior Leadership Purge
MHRA’s Rob Reid updates on timings for CE marking, pre-market SI and possible EU MDR outcomes
Redefine Modern Biotech Through Smarter Boards, Stronger ROI, and China's Rise
Europe’s Evolving Role in Global Clinical Trials
Scrip Deals Podcast: An Interview With Jeremy Levin
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 18, 2026
Scrip's Five Must-Know Things - May 18, 2026
Drug Fix: Post-Mortem On Martin Makary’s Tenure As FDA Commissioner
ABHI's Steve Lee on the UK MHRA's frictionless regulatory future for the UK
The Generics Bulletin Podcast: Biosimilars Conference Report And Big M&A Deals
Kurma’s €215m Fund And What It Says About European Funding Environment
The Scrip Awards Podcast - Call For Entries 2026, New AI Category, Triana Interview
Podcast: Inside Arcutis with CEO Frank Watanabe
How Agentic AI Could Reshape Consumer Health, With IQVIA’s Volker Spitzer
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 11, 2026
Scrip's Five Must-Know Things - May 11, 2026
Drug Fix: US FDA’s Makary Pressured To Resign, Continues Hiring, Reform Efforts
Forum chief Gwyn Tudor puts the case for medtech development in Wales
Drug Fix: The New Acting US FDA Biologics Center Director, SCOTUS Eyes Generic Drug Policy
Carna Health On Closing the Gap in CKD Prevention
What To Expect After China’s First siRNA Firm Went Public
Five-Minute Podcast: Chris Jones On Wales' Life Sciences Innovation Hub
Cracking China's Consumer Health Market, With QIVA Global's Ellie Adams
Genyro’s Adrian Woolfson on Artificial Biological Intelligence and Genome Writing
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 27, 2026
Scrip's Five Must-Know Things - Apr. 27, 2026
PD-(L)1/VEGF双抗赛道——中国可否率先改写一线肺癌标准治疗？(Chinese-language podcast)
Scrip M&A Podcast with Cooley Attorneys Kevin Cooper and Bill Roegge.
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 21, 2026
Scrip's Five Must-Know Things - Apr. 21, 2026
The Generics Bulletin Podcast: Green Regulations With Medicines for Europe’s Adrian van den Hoven
Drug Fix: CBER Director Candidate Emerges, US FDA Promotes Leucovorin Pathway
성숙기 진입 중인 ADC 시장…삼성바이오에피스, 차별화 전략 강화 (Korean-language podcast) Apr. 17, 2026
Japan Q1 Roundup: Key Commercial and Policy/Regulatory Developments
Lilly TuneLab: Breaking Data Silos in Biotech with Federated Learning
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 10, 2026
Scrip's Five Must-Know Things - Apr. 13, 2026
Drug Fix: Leucovorin’s Resurrection, PhRMA’s Leadership Change
No Matter What: How Israel Is Positioning Itself as a Global Pharma Innovation Hub
Inside Step Pharma’s Pan‑Cancer Ambition
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 6, 2026
Scrip's Five Must-Know Things - Apr. 6, 2026
China Biopharma English-Language Podcast: China’s Regulatory Changes In Cell Therapy
Five-Minute Podcast: “UK Needs To Align More With The EU”
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar. 30, 2026
Why Longevity Is The Next Big OTC Opportunity, With Euromonitor’s Magda Starula
Scrip's Five Must-Know Things - Mar.30, 2026
Drug Fix: US FDA Commissioner Martin Makary Completes First Year In Charge
Lupin’s CEO And MD On GLP-1 Strategy, Business Growth And Legacy
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.23, 2026
Scrip's Five Must-Know Things - Mar.23, 2026
Drug Fix: ACIP Next Steps After Judge Stops Work, Potential Opioid Disposal Changes
How a CDMO Created a Custom Vaccine Development Project
뇌질환 신약 개발 펀딩 부활 조짐 (Korean-language podcast) Mar.19, 2026
The Generics Bulletin Podcast: 2026 Conferences
Winning In The Probiotics Space, With David Pineda Ereño
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.16, 2026
Scrip's Five Must-Know Things - Mar.16, 2026
Drug Fix: US FDA’s Prasad Leaves, Harry Potter, And Is CNPV Effective Because Of RTOR?
Killing Cancer Loudly: Onchilles Pharma's Neutrophil-Derived Path to Pan-Cancer Therapy
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.9, 2026
Scrip's Five Must-Know Things - Mar.9, 2026
Drug Fix: The State Of Facility Inspections With Two Former Senior US FDA Execs
Unpacking Europe’s Probiotic Rules with David Pineda Ereño
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar. 2, 2026
Scrip's Five Must-Know Things - Mar.2, 2026
Drug Fix: State Of The Generics Industry, US FDA Commissioner On Compassionate Use
Affibody and the Case for Antibody Mimetics in Radioligand Therapy
글로벌 제약업계, 2026년 역풍 직면…최혜국 약가정책 영향은 제한적 (Korean-language podcast) Feb.25, 2026
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 24, 2026
Scrip's Five Must-Know Things - Feb.24, 2026
Drug Fix: ‘America First’ US FDA User Fees, Moderna’s Flu Vaccine Saga Continues
Hansa Biopharma On Clearing The Path To Kidney Transplant
ESG, Eco‑Pricing and Sustainable Packaging, with Steve Ramus
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 16, 2026
Scrip's Five Must-Know Things - Feb.16, 2026
Drug Fix: US FDA Versus Moderna And The Changing Role Of Refuse To File Actions
Preventing Lung Disease in Preterm Babies
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 9 , 2026
Scrip's Five Must-Know Things - Feb. 9, 2026
Drug Fix: US FDA Hiring Improves, But Can The Agency Avoid Oversight Erosion?
Navigating A Changing EU And US Sustainability Landscape, With Steve Ramus
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb.2, 2026
Scrip's Five Must-Know Things - Feb. 2, 2026
Drug Fix: Understanding US FDA’s CNPV Application Reviews
How Senti Bio's Programmable Cell Therapy Tackles AML's Toxicity Problem
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Jan.26, 2026
Scrip's Five Must-Know Things - Jan. 26, 2026
Scrip JPM Podcast: Dealmaking, Regulatory And Commercial Expectations For 2026
Drug Fix: US FDA Review Speed Steady In 2025, But Will Staffing Impact In 2026?
Herantis’s ‘Elegant’ Approach In Parkinson’s
【3分で解説 #世界のファーマ】第28回 ノバルティスが警鐘 自国第一主義の弊害へ (Japanese-language podcast)
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Jan.19, 2026
Scrip's Five Must-Know Things - Jan. 19, 2026
Drug Fix: Pazdur’s CNPV Problems, Could US FDA Release Unapproved Product Action Packages?
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Jan.13, 2026
Scrip이 묻다: 2026년 바이오의약품 업계 전망은? 자본배분과 딜메이킹 (Korean-language podcast)
Scrip's Five Must-Know Things - Jan. 13, 2026
Drug Fix: Oncology Stalwart Richard Pazdur Leaves US FDA
Building a Nasal First line of Defense Against H5N1
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
Scrip's Five Must-Know Things - Dec. 22, 2025
“We Are On The Cusp Of A Real Revolution”: OHC Rare Disease Center Boosts Innovation
Scrip Awards Podcast, 2025 Winners
Datamonitor Healthcare Podcast: A Deep Dive into Dry AMD
Scrip M&A Podcast: PwC's Dealmaking Preview for 2026
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
Scrip's Five Must-Know Things - Dec. 15, 2025
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
Scrip's Five Must-Know Things - Dec. 8, 2025
Overcoming Drug Resistance In Oncology With Kairos Pharma's Neil Bhowmick
Drug Fix: Understanding the US FDA’s CDER Leadership Shuffle
【3分で解説 #世界のファーマ】第27回 中国バイオ企業の成長 5つのテーマ (Japanese-language podcast)
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
Scrip's Five Must-Know Things - Dec. 1, 2025
글로벌 바이오 리더들, M&A 열기 속 낙관론 확산 (Korean-language podcast)
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
Scrip's Five Must-Know Things - Nov. 25, 2025
Charles River CSO Calls For Collaboration On Non-Animal Models
Over The Counter Special: Enabling Digital Self-Care, With PAGB’s Michelle Riddalls
Digital Health Roundup: BCIs Surge Ahead, Oura Eyes BP Clearance, AI Faces New Scrutiny
Over The Counter Special: Unlocking Switch-Driven Growth, With PAGB’s Michelle Riddalls
Data-Driven Insights Reveal The Growth Engines Powering 2026 Life Sciences
EY's Arda Ural on IPOs, Financial Markets and Tarrifs
Datamonitor Healthcare Podcast: ESMO 2025
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
Scrip's Five Must-Know Things - Nov. 10, 2025
Drug Fix: Examining George Tidmarsh’s Departure As Head Of US FDA’s Drug Center
Podcast: Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
Scrip's Five Must-Know Things - Nov. 4, 2025
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform
Decoding Cell Differentiation: How AI Foundation Models Are Reshaping Regenerative Medicine
Scrip M&A Podcast: What's Next For Dealmaking In The Obesity Space?
국내 바이오텍 펀딩 활성화를 위해 새로운 촉매제 필요 (Korean-language podcast)
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
Scrip's Five Must-Know Things - Oct. 27, 2025
Drug Fix: Another FDA Inspection Reorg, Industry Navigating New DTC Landscape
Winning Biotech Investors Through Strategic Partnerships and Trial Innovation
Innovating Autoimmune Treatment with In Vivo CAR-T
How Olon’s fully integrated, end-to-end ADC capabilities drive quality and scale
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
Scrip's Five Must-Know Things - Oct. 20, 2025
Drug Fix: US FDA Involved In Astra Zeneca’s Drug Pricing Deal, DOJ’s Off-Label Promotion Policy
Adalvo: Exploring European B2B Pharma’s Next Steps
Lupus Clinical Development Enters a New Era of Innovation
Essential Pharma – Following A Patient First Philosophy
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
Scrip's Five Must-Know Things - Oct. 14, 2025
Cereno Scientific Turns To Old Drug For Rare Cardiopulmonary Diseases
Defining the Next Era of Disruption
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Oct.7, 2025
Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes Baiao
Scrip's Five Must-Know Things - Oct. 6, 2025
Drug Fix: Government Shutdown’s Impact On US FDA, Pfizer Inks Drug Pricing Deal
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.30, 2025
Scrip's Five Must-Know Things - Sept. 30, 2025
The Generics Bulletin Podcast: Talking with AAM president and CEO John Murphy
3分で解説 #世界のファーマ】第26回 欧州の先発医薬品 米国関税15％適用へ (Japanese-language podcast) Sept.24, 2025
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.22, 2025
Scrip's Five Must-Know Things - September 22, 2025
ICROM on Innovation in HPAPI & Crystallization
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.16, 2025
Scrip's Five Must-Know Things - September 16, 2025
Drug Fix: US FDA DTC Ad Crackdown Emerges From MAHA Report
Drive Early CRO Engagement to Optimize Funding, Trial Design, and Recruitment in Biotech
Why Local Matters: A Leadership Perspective on Community-Based Trials
From Abandonment To Opportunity In Pediatric Pharma
Scrip's Five Must-Know Things - September 5, 2025
Is It Better To Be A Sustainability ‘Shaper’ Or ‘Staller’? With PA Consulting’s Rhea Patten
Drug Fix: US FDA Drops Offit, Others From Adcomms, Releases Unapproved Product Rejection Letters
China Biopharma English-Language Podcast: China Innovative Drugs And Commercial Insurance
Scrip's Five Must-Know Things - Sept. 1, 2025
Drug Fix: US FDA Changes COVID-19 Vaccine Labeling, Reimbursement Confusion Rises
Navigating What’s Next for Global Drug Development: What Sponsors Need to Know
VC가 한발 물러설 때 바이오 기업의 대체 자금원은? (Korean-language podcast)
【3分で解説 #世界のファーマ】第25回 中国、民間保険で新薬のアクセス拡大へ
How To ‘Vibe’ With Consumers, With PA Consulting’s Rhea Patten
Scrip's Five Must-Know Things - August 25, 2025
Merck KGaA's Vision For Making Digital Health Redundant
Tevard CEO Sees Hope for HIs Daughter In His Company's tRNA Platform
Scrip's Five Must-Know Things - August 15, 2025
Scrip's Five Must-Know Things - August 8, 2025
Turning Global Ambition Into Local Reality, With Haleon’s Jo Cooper
Aurigene Oncology CEO On Biotech Valuations, CAR-Ts And Reimbursement Models
Poolbeg CEO On The Biotech’s Big Bet On Small Molecules
Scrip's Five Must-Know Things - August 4, 2025
Exploring Ex-US Markets to Reduce Risk for Your Clinical Trials
The Patient Journey: Key R&D Considerations In Rheumatoid Arthritis
Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland
Scrip's Five Must-Know Things - July 28, 2025
Drug Fix: US FDA’s New Top Drug Regulator, Sarepta’s Options After Elevidys Stand-Off
MoonLake Leaders On Its Fast-Track Vision And $500m Deal
Scrip's Five Must-Know Things - July 22, 2025
Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’
Drug Fix: CBER Director’s Political Spin On COVID-19 Vaccines And US FDA RIFs Finalized
Strategic Insights into the RNA Market
Digital Health Roundup: Autonomous Robots, Medtronic’s Surgeon School, Sleep Tech & FDA Rules
“They Are Able To Keep Their Body”: Medipost On Its Stem Cell Therapy Vision
Astellas Doubles Down on Gene Therapy Despite Industry Headwinds
Scrip's Five Must-Know Things - July 14, 2025
Seizing The GLP-1 Wellness Opportunity, With Kerry Group’s Mathieu Millette
바이오 USA: 금융 시장 스트레스, 딜메이킹 기회 창출 (Korean-language podcast)
Phil L'Huillier, Scancell CEO, on the Latest Developments in Cancer Vaccines
Acuitas CSO on CRISPR Delivery Breakthrough and Innovations in Lipid Nanoparticles
Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators
How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke
Scrip's Five Must-Know Things - July 7, 2025
【3分で解説 世界のファーマ】第24回 トランプ関税 製薬大国インドへの影響 (Japanese-language podcast)
ADDF's Karen Harris: Investing in Alzheimer's Like a VC
China Biopharma English-Language Podcast: Obesity Drugs Not All About Weight Loss
Datamonitor Healthcare Podcast: ASCO 2025
Master Regulatory Hurdles and Accelerate Your Drug Development
Scrip's Five Must-Know Things - June 30, 2025
Post-BIO Podcast: Thoughts From The Frontlines
Navigating Regulatory Uncertainty: Diversity Action Plans
How to Crush Competitive Threats and Stand Out in Biotech
Scrip's Five Must-Know Things - June 23, 2025
유럽 바이오기업, 자금조달의 현주소는? (Korean-language podcast)
Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients
Unpacking EU Omnibus And Its Impact On Sustainability: With CEN Group’s Jasper Crone
Scrip's Five Must-Know Things - 16 June 2025
Drug Fix: The US and Ex-US Impact Of Most-Favored Nation Drug Pricing
Citeline Japan Awards 2025 - Entry Deadline Approaching! (Bilingual English/Japanese)
Strategies to Secure Critical Biotech Funding Amid Market Challenges
How to Survive Innovation Pressure in Today’s Biotech Landscape
Scrip's Five Must-Know Things - 9 June 2025
Drug Fix: Prasad Staying Out Of Application Reviews, US FDA Proposed Budget Cuts
A Deep Dive into Sjögren's Disease
Digital Health Roundup: Synchron Syncs With Apple, Ketryx’s AI Agents, AdvaMed’s AI RoadMap
Raj Panjabi on Flagship's Preemptive Health and Medicine Initiative
SGLT2 Inhibitors Cardiovascular and Safety Outcomes in Chronic Diseases
Plant-Based Diet Improves Outcomes in Metastatic Breast Cancer
The Generics Bulletin Podcast: The Global Generics & Biosimilars Awards 2025
Podcast: Navigating the Future of Hepatology Clinical Trials
Innovation & Integrity: The Dual Path to Success for Device Makers
Driving Innovation And Growth In France’s Self-Care Market, With Neres Luc Besançon
Scrip's Five Must-Know Things - 2 June 2025
Drug Fix: US FDA’s Private Pharma CEO Tour, HHS Changes COVID-19 Vaccine Recommendation
FDA in Transition: How Regulatory Shifts Are Redefining Drug Development
Scrip's Five Must-Know Things - 26 May 2025
Drug Fix: US FDA’s Big Vaccine Policy Week
“Powerful Yet Unexplored”: Commit Biologics Tackles The Complement System
제약바이오딜 투자수익률 하락…시장 불안정으로 상황 악화될 수도 (Korean-language podcast)
Taking Real-World Evidence Seriously, With IQVIA Consumer Health’s Volker Spitzer
Scrip's Five Must-Know Things - 19 May 2025
China Biopharma Podcast - 14 May 2025 (Chinese language)
Scrip's Five Must-Know Things - 12 May 2025
Drug Fix: A New Director For US FDA’s Biologics Center, Guidance Production Slowdowns
Scrip's Five Must-Know Things - 7 May 2025
Everything You Wanted To Know About Real World Evidence, With IQVIA’s Volker Spitzer
OPPI’s Matai On India’s IPR Regime: Progress, Pain Points, Possibilities
Drug Fix: Vaccine Review Political Interference, Missed Deadlines A Harbinger Of US FDA Problems?
Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?
Conference Catch-Up: BIO-Europe 2025
Highlights from AAN 2025
Aragen CEO On Funding Cuts At NIH, Biotechs And Likely US Pharma Tariffs
Scrip's Five Must-Know Things - 28 April 2025
Drug Fix: More US FDA Departures, Makary On Combined AE Database, ‘Conditional’ Approval
Precision Medicine in Liver Treatment: The Ochre Bio Approach
Scrip's Five Must-Know Things - 21 April 2025
Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls
Scrip's Five Must-Know Things - 14 April 2025
미국 관세 롤러코스터에 제약업계는 여전히 불안 (Korean-language podcast)
Evolving The UK Consumer Health Industry, With PAGB’s Michelle Riddalls
Scrip's Five Must-Know Things - 7 April 2025
Drug Fix: Understanding The US FDA Reduction-In-Force And Its Long-Term Impact
CEO Nicolas Poirier on OSE Immunotherapeutics Latest IL-7 Data
Digital Health Roundup: Intuitive CEO Exec Chat, Patient Monitoring, Exer Labs Woes, Roche New NGS Prototype
Scrip's Five Must-Know Things - 31 March 2025
Drug Fix: Understanding The Impact Of The Latest HHS Layoffs On The US FDA
Innovative Oncology, A Conversation with iOnctura
Podcast: Heranova CMO Advocates For Endometriosis Awareness: “Pain Is Not Normal”
What To Expect From The 61st AESGP Annual Meeting, With AESGP’s Jurate Švarcaite
Scrip's Five Must-Know Things - 24 March 2025
Drug Fix: US FDA Productivity Complaints Emerge, Internal Return To Office Headaches
Scrip's Five Must-Know Things - 17 March 2025
Drug Fix: Buyouts, Departures and Other US FDA Chaos
Scrip M&A Podcast: Looking at M&A activity as Q1 2025 nears a close.
Vaccines, Viruses & Variants: The State of COVID-19 & Flu in 2025
The Generics Bulletin Podcast: Stelara Biosimilar Launches In The US
Women’s Health Innovation And Beyond, With Maxwellia’s Anna Maxwell
Scrip's Five Must-Know Things - 10 March 2025
Grove AI and Grace, An Agentic AI For Clinical Trial Engagement
Drug Fix: What We Learned From US FDA Commissioner Nominee Makary’s Confirmation Hearing?
【3分で解説 世界のファーマ】第23回 トランプ関税 製薬への影響は (Japanese-language podcast)
트럼프의 관세 인상에 대한 엇갈린 반응 (Korean-language podcast)
The Challenge Of Innovating In A Changing OTC Industry With AdverCheck’s James Walmsley
Scrip's Five Must-Know Things - 3 March 2025
Drug Fix: Laid Off US FDA Staff Called Back, Vaccine Adcomm Cancelled, Lilly’s Manufacturing Push
Scrip's Five Must-Know Things - 25 February 2025
Why OTC Firms Should Care About Rx Advertising, With AdverCheck’s James Walmsley
Drug Fix: Understanding the US FDA Layoffs And Their Impact On Industry
Scrip's Five Must-Know Things - 18 February 2025
Drug Fix: RFK’s First Actions, Pitch To Extend Current US FDA User Fee Agreement, More Trump Impacts
Podcast: JPM Tracked and Unpacked
Scrip이 묻다... 2025년 제약바이오 산업의 미래는? 세계 정치 변화의 영향 (Korean-language podcast)
Scrip's Five Must-Know Things - 10 February 2025
Getting Creative In Consumer Health, With All Creative’s Beverley Law
Drug Fix: Kennedy’s Assurances To Gain HHS Nod, US FDA Coms Freeze Continues Thawing
Scrip's Five Must-Know Things
Harness Therapeutics CEO Talks Somatic Expansion for Neurodegeneration
Datamonitor Healthcare Podcast: Epidemiology in the Age of Real World Data and AI
Drug Fix: President Trump’s Policies Begin Changing The US FDA, Kennedy’s Hill Hearings
Scrip's Five Must-Know Things - 27 January 2025
Drug Fix: Concerns and Questions As Trump Administration Takes Control Of US FDA
Fauna Bio: Gleaning Therapeutic Insights From Animals
Scrip's Five Must-Know Things - 20 January 2025
Drug Fix: US FDA And Trump’s Reforms, CDER Director Parting Comments, 2024 Approval Trends
A “Game Changer” For The High-Risk MDS Patient Population
Scrip's Five Must-Know Things - 14 January 2025
Drug Fix: CDER Director Retires, US FDA Guidance ‘Blizzard,’ Rare Pediatric Disease Program Hangs On
2025년 JP모건 헬스케어 컨퍼런스의 주요 주제는? (Korean-language podcast)
Pre-JPM Biotech Dealmaking Roundtable
Digital Health Roundup: 2025 Will See More AI/GenAI Adoption In Medtech, FDA’s Digital Health Push
The Future of Immunotherapy
An Insight into NASH
올해의 Top 5 글로벌 제약 뉴스 (Korean language podcast) - 27 December 2024
Scrip's Five Must-Know Things - 23 December 2024
The Future Of eClinical Technology
The Generics Bulletin Podcast: Highlights Of 2024
Five Must-Know Things - 16 December 2024
The Role of Site Networks & Why They Matter
Datamonitor Healthcare Podcast: Psychedelic Symposium at the University of Wisconsin-Madison
Scrip's Five Must-Know Things - 10 December 2024
Arialys Therapeutics: Treating Autoimmune Neuropsychiatric Diseases
Drug Fix: COVID-19 Vaccine EUAs In Danger, DOGE And US FDA, New 340B Rebate Pricing Models
November 2024 Datamonitor Healthcare Podcast: Bispecific Antibodies in Oncology
Treating Rare Diseases With tRNA
Conference Catch-Up: BIO-Europe 2024
Scrip's Five Must-Know Things - 2 December 2024
Scrip Awards Podcast, Ep2: 2024 Awards Preview & Verona Pharma Interview
Drug Fix: Trump’s Potential Impact On FDA User Fees, Dr. Oz’s Potential Impact On CMS
Scrip's Five Must-Know Things - 25 November 2024
Scrip's Five Must-Know Things - 18 November 2024
Drug Fix: Trump Picks Robert F. Kennedy Jr. To Lead HHS, How Could He Disrupt FDA?
Scrip M&A Podcast: Why Did Biopharma M&A Metrics Decline During Q2 And Q3
Scrip's Five Must-Know Things - 11 November 2024
Using AI To Predict Our Immune Responses
Conference Catch-Up: Navigating the Evolving CDMO Landscape
Drug Fix: How Will Trump’s Second Term Impact The US FDA?
Digital Health Roundup: GE HealthCare On AI At HLTH; EU AI Act, Click Therapeutics
Scrip's Five Must-Know Things - 5 November 2024
【3分で解説 世界のファーマ】第22回 AD治療、費用対効果に悩む英国 (Japanese-language podcast)
Scrip's Five Must-Know Things - 28 October 2024
Conference Catch-Up: The Rise of Digital Therapeutics (Part 2)
October 2024 Datamonitor Healthcare Podcast: Insights from ESMO
Scrip's Five Must-Know Things - 21 October 2024
Drug Fix: SubQ Drugs And Price Negotiations, GLP-1s In Court, US FDA Approach To Black Box AI
빅파마가 직면한 세포유전자 치료제 시장의 현실 (Korean-language podcast)
China Biopharma Podcast - 16 October 2024 (Chinese language)
Scrip's Five Must-Know Things - 15 October 2024
Drug Fix: Inside Medicare Price Negotiations, New US FDA Vaccine Pathway
Q&A Session on Psoriasis in Pediatric Patients with Dr. Valerie Welch
COPD Treatment Strategies: Q&A with Dr. Kenneth Chinsky
Noticing Neffy – A ‘Transformative Treatment’ For Type 1 Allergies
Alpha-Synuclein Testing Comes of Age
Q&A Session: PIK3CA Mutations and Breast Cancer
Conference Catch-Up: LSX World Congress USA 2024
The Future Of Drug R&D Is Self-Driving
Drug Fix: Pfizer Pulls Sickle Cell Drug, ODAC Calls Back Approved Products, New AAM CEO
Challenges in the Development and Manufacturing of ADCs
September 2024 Datamonitor Healthcare Podcast: Radiopharmaceutical Usage is Heating Up
Health-Related Quality of Life Considerations In Clinical Trials
Over the Counter: Data Tech CEO On Digital Tools Driving Faster, More Sustainable Personal Care
Drug Fix: US FDA Worries About Celebs Endorsing Drugs, Post-Chevron Lawsuits Emerging
September 2024 Datamonitor Healthcare Podcast: Diving into the TME
The Generics Bulletin Podcast: Recent And Upcoming Industry Events
【3分で解説 世界のファーマ】第21回 中国企業 日本で続々治験開始へ (Japanese-language podcast)
J&J, '차별화된' 비만 자산에 관심있어 (Korean-language podcast)
Scrip's Five Must-Know Things - 9 September 2024
Drug Fix: Pediatric Rare Disease PRV Deadline Approaches, Potential Makena Compounding Ban
Scrip's Five Must-Know Things - 2 September 2024
Drug Fix: New US FDA Developments In AI Regulation
Digital Health Roundup: Digital Therapeutics Navigate GLP-1, Gaming; DHCoE On AI; Hello Heart
Exploring The Postbiotic Opportunity In Consumer Health, With Kerry’s Sonja Nodland
Scrip's Five Must-Know Things - 26 August 2024
August 2024 Datamonitor Healthcare Podcast: The Colorful Landscape of Therapeutic Psychedelics
Bioprinting – An Innovative Tool That Is Revolutionizing Drug Discovery
Scrip's Five Must-Know Things - 19 August 2024
Drug Fix: What We Learned From The First Batch Of Medicare Negotiated Drug Prices
【3分で解説 世界のファーマ】第20回 欧州心臓病学会 注目の新薬候補は (Japanese-language podcast)
Sustainable By Design: Thermo Fisher's Meron Mathias On ESG Compliance And The Competitive Edge
Scrip's Five Must-Know Things - 13 August 2024
Why Purpose Is Key To Driving CHC Growth, With Haleon’s Bas Vorsteveld
Drug Fix: Clinical Trial Diversity, Off-Label Standard Of Care Issues, In-Person US FDA Adcomms
Type 2 Diabetes and SGLT2 Inhibitors Q&A
비만치료제, 2024년 상반기 대형주를 지배하다 (Korean-language podcast)
Scrip's Five Must-Know Things - 5 August 2024
Drug Fix: August User Fee Goals, Oncology Trial Design Issues, EMA Review Changes
China Biotech Podcast - 2 August 2024 (Chinese language)
July 2024 Datamonitor Healthcare Podcast: The Future of Biologics in COPD
Q&A Session on the Treatment of Multiple Myeloma
How To Make An Impact With Your OTC Brand, With PA Consulting’s Rhea Patten
Scrip's Five Must-Know Things - 29 July 2024
Drug Fix: US FDA Device Director Retires, PBM Execs On Capitol Hill, Voucher Program Renewal Push
The Exciting Future of Heart Failure Management
Early Detection Key in COPD Management (Q&A with Brittany Little, NP)
Digital Health Roundup: Brain Talk; Medtronic’s Digital Tech Report OR; UK Guidance
Scrip's Five Must-Know Things - 22 July 2024
Medtech Connect 16: AI For Cross Border Regulation
Drug Fix Special: Why The US Approves Most New Drugs Before The EU
국내 AI 신약개발, 선진국과 격차 줄이려면? (Korean-language podcast)
The Importance of Exploring Genetic Potential
Scrip's Five Must-Know Things - 16 July 2024
EPR Consultant Urges Producers To Start Collecting Packaging Data
Improving Communication: The Relationship Between Biotech And Biopharma
【3分で解説 世界のファーマ】第19回 FDA「密な面談」を企業に呼び掛け (Japanese-language podcast)
Scrip's Five Must-Know Things - 8 July 2024
Scrip M&A Podcast: A Midyear Review of Biopharma Dealmaking and Expectations of What's Ahead
Non-Invasive Solutions: Exploring The Role Of Breath Biopsies In Early Detection
In Vivo Podcast Episode with Stefan Woxström
How To Innovate For The Ages, With Bayer’s Reese Fitzpatrick And Rachel Koontz
Scrip's Five Must-Know Things - 1 July 2024
Drug Fix: What’s In And Out Of US FDA’s Diversity Action Plan Guidance, AI Guidance Also Coming
China Biotech Podcast - 26 June 2024 (Chinese language)
Scrip's Five Must-Know Things - 24 June 2024
Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic, Lung LB
The Power Of Herbs For Women’s Wellness, With The SABI’s Hilary Metcalfe and Anna Cave-Bigley
Scrip's Five Must-Know Things - 17 June 2024
Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond
June 2024 Datamonitor Healthcare Podcast: ASCO 2024
China Biotech Podcast - 14 June 2024 (Bilingual Chinese/English)
ASCO 결산: 암 연구의 미래는? (Korean-language podcast)
Scrip's Five Must-Know Things - 10 June 2024
The Generics Bulletin Podcast: Teva, Sandoz, Sawai and US Orange Book patents
China Biotech Podcast - 5 June 2024 (Chinese language)
JB CEO On CDMO Growth, Red Sea Crisis And More
Scrip's Five Must-Know Things - 3 June 2024
The Scrip Awards Podcast. Episode 1: Genmab: The Ongoing Evolution Of Europe’s Antibody Powerhouse
How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone
Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions
'CorpPharma Is Not Just A Cost Component’ – Showcasing Value As Well As Innovation
China Biotech CEO Interview - NeuShen's Joan Huaqiong Shen
Citeline Japan Awards 2024 - Enter Now! (Bilingual English/Japanese)
Scrip's Five Must-Know Things - 27 May 2024
Drug Fix: Novel Clinical Trial Reg Problems, NIH Drug ‘Access Plans’, Good Ole Days Of Woodcock
【3分で解説 世界のファーマ】第18回 GLP-1を超える肥満治療薬のカギとは？(Japanese-language podcast)
Closed Loop Medicine: Pairing Software With Drugs To Optimize Dosing
Leading PRO Discusses Plans For Administering State EPR Programs
개발 VS 딜메이킹: 블록버스터 신약을 확보하는 방법 (Korean-language podcast)
How To Grow A Consumer Health Brand, With TheOTCLab’s Albert Swane
Scrip's Five Must-Know Things - 20 May 2024
Drug Fix: BIOSECURE Act Advances, Trial Diversity Sticks, Platform Principles Without Designation
May 2024 Datamonitor Healthcare Podcast: Neoadjuvant Therapy in Melanoma
China Biotech Podcast - 15 May 2024 (Chinese- and English-Language)
Scrip's Five Must-Know Things - 13 May 2024
Episode 15: Digital Trust
Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta
Scrip's Five Must-Know Things - 7 May 2024
Drug Fix: US FDA Adcomm Reform, A Boost For Clinical Trial Modeling, AI For Drug Review
Digital Health Roundup: US FDA’s ‘Idea Lab’; Philips’ Roy Jakobs On AI Draft Framework; Apple Watch
April Datamonitor Podcast 2024: AAN coverage
Scrip's Five Must-Know Things - 30 April 2024
2024 Global Generics & Biosimilars Awards
Podcast: Facilitating Patient Monitoring in CAR-T Development
Drug Fix: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics
Dr. Xue Discusses Treatment Guideline Updates for COPD in This Q&A Session
China Biotech Podcast - 26 April 2024 (Chinese and English Language)
Future Governance & Oversight of the EU Medtech Regulatory System
Citeline - Cerba Research Podcast V2
Scrip M&A Podcast: Are Buyers Coming For Viking, Verona, Altimmune, Xenon And Crinetics
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
Helping Consumers ‘Tune In’ To Reliable Health Information, With Kaizo’s Anita Nahal
Scrip's Five Must-Know Things - 22 April 2024
Drug Fix: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Next-Generation Diagnostics: "Breathomics" From Imspex
Ratio Therapeutics On BMS Buy-In, Radiopharma R&D Trends, AI And Assets
China Biotech Podcast (Chinese- and English-language) - April 2024
Scrip's Five Must-Know Things - 15 April 2024
Drug Fix: US FDA Adcomm Open Public Hearings, Clinical Trial Diversity Plans, Stealth’s Elamipretide
In Conversation With 2024 In Vivo Rising Leader, Hanadie Yousef
Scrip's Five Must-Know Things - 8 April 2024
Drug Fix: Relyvrio And Public Promises, Allergy Biomarker Adcomms, PMDA In The USA
Medtech Connect Episode 14: Live From HIMSS 2024
피노바이오, 국내 ADC 생태계 발전에 기여할 것 (Korean-language podcast)
Scrip's Five Must-Know Things - 1 April 2024
Analysing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
March Datamonitor Podcast 2024: The US Inflation Reduction Act
Scrip's Five Must-Know Things - 26 March 2024
Drug Fix: Mifepristone And Misinformation At SCOTUS, Understanding US FDA’s ODAC
China Biotech Podcast (Chinese language) - March 2024
Digital Health Roundup: EU’s AI Act Impact; Verily's Andrew Trister’s Vision For Personal AI Agent
Scrip's Five Must-Know Things - 18 March 2024
How AI Is Revolutionizing Personalized Wellness, With Bioniq’s Marni Allen
【3分で解説 世界のファーマ】第17回 LSDで不安症を治療 第III相開始へ (Japanese-language podcast)
"Identifying The 80% Of Undiagnosed And Misdiagnosed Patients"
Scrip's Five Must-Know Things - 11 March 2024
Drug Fix: Vanda Appeals US FDA Jet Lag Denial In Court, Mark Cuban Battles PBMs, Austere FDA Budget
Scrip이 묻다: 2024년 제약바이오업계 전망은? 치료영역의 발전 (Korean-language podcast)
Medtech Connect Episode 13: Augmented Reality In Surgery
Scrip's Five Must-Know Things - 4 March 2024
Cardio Conversations: iRhythm CEO Blackford Talks AI Arrhythmia Diagnostics
The Emerging Benefits Of ‘Beauty-From-Within,’ Featuring Kenvue’s Paul LaTerra
February Datamonitor Podcast: 2024 Clinical Outlook
NodThera On The Role Of The Brain In Driving Chronic Disease
Scrip's Five Must-Know Things - 26 February 2024
Drug Fix: US FDA And Psychedelic Drugs, Aduhelm Clinical Trial Data, Adcomm Candidates
AESGP’s 60th Birthday Celebrations In 2024 Including Annual Meeting, With Jurate Švarcaite
Drug Fix: Price Negotiation Suit Tossed, Drug Shortage Probe, FDA-Approved Marijuana
Drug Fix: State Of The Generic Industry, US FDA Under Second Trump Term, Inspections And Shortages
China Biotech Podcast (Chinese and English Language) - February 2024
혁신 육성 전략에 기반한 한국의 제약바이오 강국 야망 (Korean-language podcast)
Trio Of Diagnostics Execs Weigh In On Upcoming Challenges
China Biotech Podcast - Interview With BeiGene Co-Founder Xiaodong Wang
Title: The Promise Of AI For Consumer Health, Pt 2, With The Exponential Club’s Nick Tate
Scrip's Five Must-Know Things - 5 February 2024
Digital Health Roundup: CES Biggest Hits; Apple Versus Masimo; Insulet Recalls Diabetes App
Automating Cell Therapy Manufacturing: Cellular Origins' CEO Talks Robotics
Scrip's Five Must-Know Things - 29 January 2024
Medtech Connect Episode 12: Apple’s Patent Infringement Cases
Drug Fix: Janet Woodcock And The US FDA’s G.O.A.T., Puberty Blockers Meeting, CAR-T Safety
Q&A Session on Treatment of LBCL With Oncologist Donald Fleming, MD
The Promise Of AI For Consumer Health, Pt 1, With The Exponential Club’s Nick Tate
Drug Fix: US FDA Adcomm Schedule, CMS And Drug Importation, Missed User Fee Goals
China Biotech Podcast - Major Takeaways From JPM (January 2024 - Chinese-Language)
【3分で解説 世界のファーマ】第16回 JPモルガンで見えた2024年の製薬業界 (Japanese-language podcast)
Scrip's Five Must-Know Things - 15 January 2024
Pennine Health Talks Sustainability Compliance and ESG Initiatives
Drug Fix: Project Orbis For Gene Therapy, US FDA Leaders’ 2024 Predictions, FDA and AI
Building A Biotech: Exploring ILC’s Hybrid Interferon Platform
전 세계 비만 치료제 임상시험 건 수, 미국이 가장 높아…한국은 9위 (Korean-language podcast)
Scrip's Five Must-Know Things - 10 January 2024
Podcast: Current trends in the biotech landscape with Chris Smyth, President, ICON Biotech Solutions
China Biotech Podcast - January 2024 (Chinese-language)
Cardio Conversations: AVS Cracks Calcium With Novel Pressure Wave Balloon
Drug Fix: Looking Back And Looking Ahead: Key US and EU Legislation
Unlock the Future of Cancer Detection with Dr Charles P. Vega, MD, FAAFP: Listen Now!
The Challenges of Rare Neurological Disease Drug Development
【3分で解説 世界のファーマ】第15回 治験に被験者の「多様性」を 米国の課題 (Japanese-language podcast)
Medtech Connect Episode 11: A Look Back At 2023
Biopharma’s Must-Know 2023-4 Catalysts
Scrip’s Five Must-Know Things – 19 December 2023
Drug Fix: Taking A Look Back, And Forward, With US FDA’s Project Orbis
China Biotech Podcast - December 2023 (Chinese-language)
Scrip’s Five Must-Know Things – 11 December 2023
Over the Counter 7 Dec 2023: IFRA On Potential Impact Of EU's CLP Revision
제약업계의 생성형AI 적용 성공의 열쇠는? (Korean-language podcast)
Scrip's Five Must-Know Things - 4 December 2023
Drug Fix: CAR-T Malignancy Reports, Background Music In DTC Ads, New No. 2 At US FDA
RNA And Kidneys And Diagnostics RNA, Oh My – Discussing Verici DX’s Differentiated Product Offering
Scrip’s Five Must-Know Things – 27 November 2023
Trends In Epidemiology
Scrip Lifetime Achievement Award 2023: Jeremy Levin’s Acceptance Speech
China Biotech Podcast (Chinese language) - November 2023
Discussing The Potentials Of And Challenges For Digital Therapeutics
Digital Health Roundup: Black Friday Hits – Digital Twins, Biowearables, Robotics, Cardiology
Scrip’s Five Must-Know Things – 20 November 2023
Drug Fix: Janet Woodcock retiring, Accelerated Approval Reform, US FDA Meeting Recording Policy